Journal of materials science. Materials in medicine

In-situ hybridization of calcium silicate and hydroxyapatite-gelatin nanocomposites enhances physical property and in vitro osteogenesis.

PMID 25649517


Low mechanical strengths and inadequate bioactive material-tissue interactions of current synthetic materials limit their clinical applications in bone regeneration. Here, we demonstrate gelatin modified siloxane-calcium silicate (GEMOSIL-CS), a nanocomposite made of gelatinous hydroxyapatite with in situ pozzolanic formation of calcium silicate (CS) interacting among gelatin, silica and Calcium Hydroxide (Ca(OH)2). It is shown the formation of CS matrices, which chemically bonds to the gelatinous hydroxyapatite, provided hygroscopic reinforcement mechanism and promoted both in vitro and in vivo osteogenic properties of GEMOSIL-CS. The formation of CS was identified by Fourier transform infrared spectroscopy (FTIR) and powder X-ray diffraction. The interfacial bindings within nanocomposites were studied by FTIR and thermogravimetric analysis. Both gelatin and CS have been found critical to the structure integrity and mechanical strengths (93 MPa in compressive strength and 58.9 MPa in biaxial strength). The GEMOSIL-CS was biocompatible and osteoconductive as result of type I collagen secretion and mineralized nodule formation from MC3T3 osteoblasts. SEM and TEM indicated the secretion of collagen fibers and mineral particles as the evidence of mineralization in the early stage of osteogenic differentiation. In vivo bone formation capability was performed by implanting GEMOSIL-CS into rat calvarial defects for 12 weeks and the result showed comparable new bone formation between GEMOSIL-CS group (20%) and the control (20.19%). The major advantage of GEMOSIL-CS composites is in situ self-hardening in ambient or aqueous environment at room temperature providing a simple, fast and cheap method to produce porous scaffolds.